➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
Colorcon
Harvard Business School
Boehringer Ingelheim

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. SUN PHARMA GLOBAL FZE (D.N.J. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ASTRAZENECA AB v. SUN PHARMA GLOBAL FZE (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-02-26
Court District Court, D. New Jersey Date Terminated 2011-10-12
Cause 15:1126 Patent Infringement Assigned To Joel A. Pisano
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties AKTIEBOLAGET HASSLE; ASTRAZENECA AB; ASTRAZENECA LP; CARACO PHARMACEUTICAL LABORATORIES LTD; KBI INC,; KBI-E INC; SUN PHARMA GLOBAL FZE; SUN PHARMA GLOBAL INC; SUN PHARMACEUTICAL INDUSTRIES INC; SUN PHARMACEUTICAL INDUSTRIES LTD
Patents 6,143,771
Attorneys CARISSA L. RODRIGUE; ELINA SLAVIN; JAMES S. RICHTER; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; MELISSA STEEDLE BOGAD; SYMONE J. REDWINE; WILLIAM J. HELLER
Firms McCarter & English, LLP; McCarter and English, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA AB v. SUN PHARMA GLOBAL FZE
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for ASTRAZENECA AB v. SUN PHARMA GLOBAL FZE (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-02-26 1 United States Patent Nos. 5,877,192 (the “’192 patent”) and 6,143,771 (the “’771 patent”), by, inter … 1. This is an action for patent infringement arising under the Patent and Food and Drug laws of the…Lars Weidolf. The patent was subsequently assigned to AstraZeneca AB. The ’192 patent claims, inter alia…been and still is the owner of the ’192 patent. The ’192 patent will expire on May 27, 2014 and pediatric… the ANDA applicant that the subject patent, here the ’192 patent, “is invalid or will not be infringed External link to document
2010-04-06 10 United States Patent Nos. 5,877,192 (the “‘192 patent”) and 6,143,771 (the “‘771 patent”), by, inter alia…Defendants allege that United States Patent No. 6,143,771 (the “‘771 patent”) is currently owned by AstraZeneca… Declaring that the claims of U.S. Patent No. 6,143,771 are invalid; … Declaring that any valid claims of U.S. Patent No. 6,143,771 are not and will not be infringed by the… action for infringement of U.S. Patent Nos. 5,877,192 or 6,143,771 against Sun or any related entities External link to document
2011-10-12 127 judgment declaring that United States Patent Numbers 5,877,192 and 6,143,771 have been infringed pursuant to…claims that seek judgment declaring that the US Patents have been infringed. Signed by Judge Joel A. Pisano…2010 12 October 2011 3:10-cv-01017 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
McKinsey
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.